Search This Blog

Thursday, May 2, 2019

Alder Biopharmaceuticals reports Q1 EPS ($1.63), consensus ($1.03)

As of March 31, Alder had $498.5M in cash, cash equivalents, investments and restricted cash, compared to $412.4M as of December 31, 2018.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)